Multihydroxylated [[email protected] C82 (OH) 22] n nanoparticles: antineoplastic activity of high efficiency and low toxicity

Author(s): Chen C, Xing G, Wang J, Zhao Y, Li B, et al.


[Gd@C82(OH)22]n particles (22 nm in a saline solution) of a dose level as low as 10-7 mol/kg exhibit a very high antineoplastic efficiency (∼60%) in mice. A dose increment of 1 × 10-7 mol/kg increases the tumor inhibition rate 26%. [Gd@C82(OH)22]n particles have a strong capacity to improve immunity and interfere with tumor invasion in normal muscle cells, nearly without toxicity in vivo and in vitro. Unlike conventional antineoplastic chemicals, the high antitumor efficiency of nanoparticles is not due to toxic effects to cells because they do not kill the tumor cells directly and only about 0.05% of the used dose is found in the tumor tissues. Results suggest that fullerene derivatives with proper surface modifications and sizes may help realize the dream of tumor chemotherapeutics of high-efficacy and low-toxicity.

Similar Articles

Hallmarks of cancer: the next generation

Author(s): Hanahan D, Weinberg RA

Side effects of chemotherapy

Author(s): Burstein HJ

Therapeutic nanoparticles for drug delivery in cancer

Author(s): Cho K, Wang X, Nie S, Chen ZG, Shin DM

Synthesis of biocompatible Au–ZnTe core–shell nanoparticles

Author(s): Dunpall R, Lewis EA, Haigh SJ, O'Brien P, Revaprasadu N

Nanomaterial cytotoxicity is composition, size, and cell type dependent

Author(s): Sohaebuddin SK, Thevenot PT, Baker D, Eaton JW, Tang L

Nanoparticle and targeted systems for cancer therapy

Author(s): Brannon-Peppas L, Blanchette JO

Core–shell-type lipid–polymer hybrid nanoparticles as a drug delivery platform

Author(s): Mandal B, Bhattacharjee H, Mittal N, Sah H, Balabathula P,et al.